AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

ANIMALCARE GROUP PLC

Remuneration Information Apr 29, 2022

7488_dirs_2022-04-29_57d58253-b374-4e01-8a4b-ca1f7548122f.html

Remuneration Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 9200J

Animalcare Group PLC

29 April 2022

ANIMALCARE GROUP PLC

(the "Company" or the "Group")

Grant of options and PDMR Dealing

29 April 2022. Animalcare Group plc (AIM: ANCR), the international animal health business, announces that, on 28 April 2022, nil-cost options over a total of 302,037 ordinary shares with a nominal value of 20p per share ("the Options") were awarded to the Executive Directors and PDMRs of the Company and to members of the Senior Executive Team pursuant to the Company's Long Term Incentive Plan.

The awards will vest on 1 July 2025 following the assessment of performance criteria based on Earnings Per Share (EPS) growth per annum and Total Shareholder Return (TSR) over a three-year financial period ending 30 June 2025 which are as follows:

Earnings Per Share growth per annum Extent to which EPS tranche will vest
Less than 3% 0%
3% 25%
10% 100%
Between 3% and 10% Between 25% and 100% on a straight line basis
Rank of the Company's TSR compared to the Comparator Group Extent to which the TSR tranche will vest
Upper quartile or above 100%
Between median and upper quartile Pro rata between 25% and 100% on a ranking basis
Median 25%
Below median 0%

50% of the option award will be subject to the EPS performance condition and the remaining 50% will be subject to the TSR performance condition. Accordingly, if one of the performance conditions is met but the other is not, the Option award will only vest as per the above.

After the grant of the Options, the PDMRs set out below hold the following Options and ordinary shares:

PDMR Options Awarded Total Options Ordinary Shares
Jennifer Winter 130,620 580,795 7,000
Chris Brewster 53,488 240,778 280,513

Options over a further 117,929 ordinary shares were granted to other members of the Senior Executive Team and Leadership Team.

The notification in respect of the Option Awards set out in the Annex below was made subject to the requirements of Article 19 of the Market Abuse Regulation:

ANNEX

1 Details of the person discharging managerial responsibilities / person closely associated
a) Name Jennifer Winter, Chief Executive Officer
2 Reason for the notification
a) Position/status See 1(a) above - Ms Winter is classified as a PDMR of the Company
b) Initial notification

/Amendment
Initial Notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Ani

malcare Group plc
b) LEI 213800A7XPQ528RMCC72
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Options in respect of the Long Term Incentive Plan ("LTIP") over ordinary shares of 20p each
b) Identification code GB0032350695
c) Nature of the transaction(s) Award of options
d) Price(s) and volume(s) Volume(s):

Nil cost options over 130,620 shares

Price: £Nil
e) Aggregated information

- Aggregated volume

- Price
N/A
f) Date of the transaction 28 April 2022
g) Place of the transaction Outside a trading venue
1 Details of the person discharging managerial responsibilities / person closely associated
a) Name Chris Brewster, Chief Financial Officer
2 Reason for the notification
a) Position/status See 1(a) above - Mr Brewster is classified as a PDMR of the Company
b) Initial notification

/Amendment
Initial Notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Animalcare Group plc
b) LEI 213800A7XPQ528RMCC72
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Options in respect of the Long Term Incentive Plan ("LTIP") over ordinary shares of 20p each
b) Identification code GB0032350695
c) Nature of the transaction(s) Award of options
d) Price(s) and volume(s) Volume(s):

Nil cost options over 53,488 shares Price: £Nil
e) Aggregated information

- Aggregated volume

- Price
N/A
f) Date of the transaction 28 April 2022
g) Place of the transaction Outside a trading venue

Enquiries:

Animalcare Group plc
Chris Brewster, Chief Financial Officer and

Company Secretary
+44 (0)1904 487 687 

[email protected]
Stifel Nicolaus Europe Limited

(Nominated Adviser & Joint Broker)
+44 (0)20 7710 7600
Ben Maddison

Nicholas Harland

Nick Adams
Panmure Gordon

(Joint Broker)
+44 (0)20 7886 2500
Corporate Finance:

Freddy Crossley/Emma Earl

Corporate Broking:

Rupert Dearden

About Animalcare 

Animalcare Group plc is a UK AIM-listed international development-focused veterinary sales and marketing organisation. Animalcare operates in seven countries and exports to approximately 40 countries in Europe and worldwide. The Group is focused on bringing new and innovative products to market through its own development pipeline, partnerships and via acquisition.

For more information about Animalcare, please visit www.animalcaregroup.com 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHSEMFDUEESEFL

Talk to a Data Expert

Have a question? We'll get back to you promptly.